FDA Inspection 1266438 — Zambon Switzerland Ltd.
The FDA completed an inspection of Zambon Switzerland Ltd. on December 12, 2024 in Cadempino. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 12, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cadempino (Switzerland)
Additional Details
Mutual Recognition Agreement (MRA)